361 related articles for article (PubMed ID: 27213582)
21. Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.
Santen RJ; Fan P; Zhang Z; Bao Y; Song RX; Yue W
Steroids; 2009 Jul; 74(7):586-94. PubMed ID: 19138696
[TBL] [Abstract][Full Text] [Related]
22. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A
Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
24. IGF-I/EGF and E2 signaling crosstalk through IGF-IR conduit point affects breast cancer cell adhesion.
Voudouri K; Nikitovic D; Berdiaki A; Kletsas D; Karamanos NK; Tzanakakis GN
Matrix Biol; 2016 Dec; 56():95-113. PubMed ID: 27353258
[TBL] [Abstract][Full Text] [Related]
25. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
[TBL] [Abstract][Full Text] [Related]
26. Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.
Mendoza RA; Enriquez MI; Mejia SM; Moody EE; Thordarson G
J Endocrinol; 2011 Jan; 208(1):1-9. PubMed ID: 20974640
[TBL] [Abstract][Full Text] [Related]
27. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
[TBL] [Abstract][Full Text] [Related]
28. Growth factors change nuclear distribution of estrogen receptor-alpha via mitogen-activated protein kinase or phosphatidylinositol 3-kinase cascade in a human breast cancer cell line.
Takahashi T; Ohmichi M; Kawagoe J; Ohshima C; Doshida M; Ohta T; Saitoh M; Mori-Abe A; Du B; Igarashi H; Takahashi K; Kurachi H
Endocrinology; 2005 Sep; 146(9):4082-9. PubMed ID: 15947004
[TBL] [Abstract][Full Text] [Related]
29. A ligand-based and enediyne-energized bispecific fusion protein targeting epidermal growth factor receptor and insulin-like growth factor-1 receptor shows potent antitumor efficacy against esophageal cancer.
Cao HY; Guo XF; Zhu XF; Li SS; Zhen YS
Oncol Rep; 2017 Jun; 37(6):3329-3340. PubMed ID: 28498434
[TBL] [Abstract][Full Text] [Related]
30. Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
Wang J; Barnes RO; West NR; Olson M; Chu JE; Watson PH
Breast Cancer Res; 2008; 10(3):R51. PubMed ID: 18534028
[TBL] [Abstract][Full Text] [Related]
31. Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells.
Yang Y; Chan JY; Temiz NA; Yee D
Horm Cancer; 2018 Dec; 9(6):371-382. PubMed ID: 30229539
[TBL] [Abstract][Full Text] [Related]
32. β-Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer.
Xu C; Liu F; Xiang G; Cao L; Wang S; Liu J; Meng Q; Xu D; Lv S; Jiao J; Niu Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):238. PubMed ID: 31171012
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
34. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
35. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
37. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.
Nasser MW; Qamri Z; Deol YS; Smith D; Shilo K; Zou X; Ganju RK
PLoS One; 2011; 6(9):e23901. PubMed ID: 21915267
[TBL] [Abstract][Full Text] [Related]
38. Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.
Modha G; Blanchard A; Sidorchuk J; Venditti M; Shiu R; Myal Y
Endocrine; 2003 Dec; 22(3):293-303. PubMed ID: 14709803
[TBL] [Abstract][Full Text] [Related]
39. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM
Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637
[TBL] [Abstract][Full Text] [Related]
40. Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth.
Casa AJ; Potter AS; Malik S; Lazard Z; Kuiatse I; Kim HT; Tsimelzon A; Creighton CJ; Hilsenbeck SG; Brown PH; Oesterreich S; Lee AV
Breast Cancer Res Treat; 2012 Feb; 132(1):61-73. PubMed ID: 21541704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
